Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults.
HYDROCORTISONE AND ACETIC ACID — TARO, approved 2005-04-28 (ANDA088759).
140,606 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.